Radiopharmaceuticals: FDA draft guidance offers tailored approach for optimizing dose
Regulatory NewsJoanne S. Eglovitch
Approval/marketing authorizationCDERChemistry, Manufacturing and Controls (CMC)GuidancePharmaceuticalsProduct developmentRegulatory Intelligence/PolicyUnited States